Dexamethasone Sodium Phosphate NDC 24208-720

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-720Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0720Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24208-720-02	24208072002	1 BOTTLE, DROPPER in 1 CARTON (24208-720-02) / 5 mL in 1 BOTTLE, DROPPERMarketed from Jul 26, 1996

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone Sodium Phosphate
Generic name (nonproprietary): dexamethasone sodium phosphate
Active ingredients: Dexamethasone sodium phosphate — 1 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Bausch & Lomb Incorporated
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040069
Marketing start: Jul 26, 1996
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 24208-720_466190ae-63f8-4b89-a71e-f1b91f90c764SPL ID 466190ae-63f8-4b89-a71e-f1b91f90c764SPL set ID 6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73RxCUI 226343UNII AI9376Y64P
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208072002 followed by a unit qualifier and the quantity

Package 24208-0720-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 31, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE For the treatment of the following conditions: Ophthalmic: Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical or thermal burns, or penetration of foreign bodies. Otic: Steroid responsive inflammatory conditions of the external auditory meatus, such as allergic otitis externa, selected purulent and nonpu…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)